Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FK-330 (FR-260330) is a novel orally active inducible nitric oxide synthase inhibitor with potential anticancer and antitumor activity that prevents ischemia and reperfusion injury in rat liver transplantation.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 45,000 | |||
5 mg | 在庫あり | ¥ 111,000 | |||
10 mg | 在庫あり | ¥ 159,000 | |||
25 mg | 在庫あり | ¥ 248,000 | |||
50 mg | 在庫あり | ¥ 342,000 | |||
100 mg | 在庫あり | ¥ 452,500 | |||
500 mg | 在庫あり | ¥ 902,000 |
説明 | FK-330 (FR-260330) is a novel orally active inducible nitric oxide synthase inhibitor with potential anticancer and antitumor activity that prevents ischemia and reperfusion injury in rat liver transplantation. |
別名 | LS-192510, FR-260330, FK330, FK 330 |
分子量 | 617.02 |
分子式 | C29H28ClF3N6O4 |
CAS No. | 442198-67-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (81.03 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
FK-330 442198-67-6 Immunology/Inflammation NOS LS-192510 FR-260330 FR 260330 LS192510 FK330 LS 192510 FR260330 FK 330 Inhibitor inhibitor inhibit